News & Events

Press release October 13, 2016

 Download as PDF

 

BrainCool makes a strategic acquisition in purchasing all assets of the American medical cooling company Benechill Inc

BrainCool AB (publ), a Swedish medical device company with a focus on medical cooling and temperature management listed on Aktietorget, has acquired the entire business of Benechill Inc through an asset deal. The acquisition includes all assets such as patents, trademarks, all rights to the product RhinoChill® and a finished goods inventory. The transaction, with a total purchase of 19 million SEK, will be settled in cash and new shares , of which the major part is in shares.  The complete purchase price allocation will be fully presented in the next regulatory filling of BrainCool AB Benechill was founded in 2004 with a focus on rapid medical cooling technologies. The company has developed the medical device RhinoChill IntraNasal Cooling System. The RhinoChill has a number of advantages. It is portable, battery operated, non-invasive and provides early-stage and rapid cooling by means of a catheter that sprays coolant liquid into the nasal cavity. It addresses pre-hospital treatment such as in ambulances and by rescue services as well as in the emergency room.

Upcoming Events 

euroPCR
15 - 18 May 2012
Paris, France

European Stroke Conference
22 May 2012 to 25 May 2012
Lisbon, Portugal. 

ESICM LIVES 2012
13 - 17 October 2012
Lisbon, Portugal

Resuscitation 2012
18 - 20 October 2012
Vienna, Austria

Members of the Media

For more information about Benechill and therapeutic hypothermia, please email media@benechill.com.